Surgery Historical Cash Flow
| SGRY Stock | USD 23.84 0.43 1.84% |
Analysis of Surgery Partners cash flow over time is an excellent tool to project Surgery Partners future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 246.9 M or Capital Expenditures of 46.2 M as it is a great indicator of Surgery Partners ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Surgery Partners latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Surgery Partners is a good buy for the upcoming year.
Surgery |
About Surgery Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Surgery balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Surgery's non-liquid assets can be easily converted into cash.
Surgery Partners Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Surgery Partners to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Surgery Partners operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Surgery Partners' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Surgery Partners current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.At this time, Surgery Partners' Free Cash Flow is fairly stable compared to the past year. Other Non Cash Items is likely to rise to about 246.9 M in 2024, despite the fact that Change In Cash is likely to grow to (82.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Free Cash Flow | 29.5M | 78.2M | 205M | 215.3M | Stock Based Compensation | 17.4M | 18.4M | 17.7M | 9.5M |
Surgery Partners cash flow statement Correlations
Click cells to compare fundamentals
Surgery Partners Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Surgery Partners cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (91.6M) | 225.2M | 71.7M | (107M) | (87M) | (82.7M) | |
| Stock Based Compensation | 10.2M | 13.2M | 17.4M | 18.4M | 17.7M | 9.5M | |
| Free Cash Flow | 55.9M | 204M | 29.5M | 78.2M | 205M | 215.3M | |
| Change In Working Capital | (68.8M) | 75.9M | (149.1M) | (160.7M) | (63.5M) | (60.3M) | |
| Begin Period Cash Flow | 184.6M | 93M | 318.2M | 389.9M | 282.9M | 152.0M | |
| Other Cashflows From Financing Activities | 372.7M | (146.4M) | 316.3M | (196.6M) | (174.7M) | (166.0M) | |
| Depreciation | 76.5M | 94.8M | 98.8M | 114.8M | 118.1M | 67.3M | |
| Other Non Cash Items | 58M | 83.6M | 40.4M | 77.4M | 235.1M | 246.9M | |
| Capital Expenditures | 73.6M | 42.9M | 57.6M | 80.6M | 88.8M | 46.2M | |
| Total Cash From Operating Activities | 129.5M | 246.9M | 87.1M | 158.8M | 293.8M | 308.5M | |
| Change To Account Receivables | (23.5M) | (46.6M) | (32.1M) | (35.3M) | (47.2M) | (49.6M) | |
| Net Income | 45.1M | 1.3M | 70.7M | 87M | (11.9M) | (11.3M) | |
| Total Cash From Financing Activities | (135.9M) | 66.7M | 316.3M | 42.1M | (155.2M) | (147.4M) | |
| End Period Cash Flow | 93M | 318.2M | 389.9M | 282.9M | 195.9M | 160.9M | |
| Dividends Paid | 7.8M | 121.2M | 109.6M | 5.1M | 146.8M | 0.0 | |
| Other Cashflows From Investing Activities | 3.6M | (45.5M) | (274.1M) | (145M) | (130.5M) | (137.0M) | |
| Sale Purchase Of Stock | (3.2M) | (27.4M) | (233.5M) | 854.3M | 982.4M | 1.0B | |
| Net Borrowings | 7.2M | 204.6M | (55.5M) | (644.2M) | (579.8M) | (550.8M) | |
| Total Cashflows From Investing Activities | (85.2M) | (88.4M) | (331.7M) | (307.9M) | (354.1M) | (371.8M) | |
| Change To Operating Activities | (45.3M) | 122.5M | (149.2M) | (125.4M) | (112.9M) | (107.2M) | |
| Change To Netincome | 38.6M | 25.3M | 35.6M | 45.9M | 41.3M | 54.4M | |
| Change Receivables | (23.5M) | (46.6M) | (32.1M) | (35.3M) | (40.6M) | (42.6M) | |
| Cash And Cash Equivalents Changes | (91.6M) | 225.2M | 71.7M | (107M) | (123.1M) | (116.9M) | |
| Cash Flows Other Operating | (47.2M) | 172.1M | (85.9M) | (53.6M) | (48.2M) | (45.8M) | |
| Investments | (15.2M) | (88.4M) | (331.7M) | (82.3M) | (239.7M) | (251.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.